ArticleScientific reports2022

C-reactive protein cut-off for early tocilizumab and dexamethasone prescription in hospitalized patients with COVID-19.

Ana M Camon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.